NEW YORK (GenomeWeb News) — Contract research company BioFocus DPI said today that it has installed a Waters Xevo TQ Mass Spectrometer for use in its drug metabolite discovery services for pharmaceutical clients.

Using the Xevo alongside Waters' UltraPerformance liquid chromatography technology will increase the lab’s throughput and "allows more accurate measurements to both quantify and confirm the identity of metabolites in a wide range of biological fluids and tissues," enabling an increased likelihood of metabolite detection, the company said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

NPR reports that with medical data being big business, some companies want to get patients involved.

The Asbury Park Press reports on the startup Genomic Prediction's test to determine an embryo's risk of disease.

In PNAS this week: optical mapping allows glimpse of structural variants, disease-linked GATA2 mutations boosts its protein activity, and more.

Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.